Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 06, 2026 06:52 ET | Source: Janssen Cilag International NV

Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma

Novel immunotherapy combination regimen brings together two complementary therapies to improve outcomes for people living with multiple myeloma as early as second line1 The application is supported...
December 19, 2025 09:14 ET | Source: Janssen Cilag International NV

European Commission approves TREMFYA® (guselkumab) for the treatment of children with plaque psoriasis, marking the first paediatric indication for an IL-23 inhibitor

Guselkumab has received approval for moderate to severe plaque psoriasis in children and adolescents from the age of 6 years who are candidates for systemic therapy.1 The decision is supported by the...
December 10, 2025 09:28 ET | Source: Precedence Research

3D Printing Materials Market Size to Worth USD 31.23 Billion by 2035 - Exclusive Report by Towards Chemical and Materials

The global 3D Printing Materials market is projected to grow from USD 4.66 billion in 2025 to USD 31.23 billion by 2035 at a CAGR of 20.96%
December 09, 2025 09:21 ET | Source: Janssen Cilag International NV

Unprecedented results from the Phase 3 MajesTEC-3 study support TECVAYLI®▼ (teclistamab) plus DARZALEX® (daratumumab) subcutaneous formulation as a potential standard of care as early as second line for patients with relapsed/refractory multiple myeloma

Teclistamab and daratumumab subcutaneous (SC) combination led to a statistically significant progression-free survival and overall survival advantage compared to standard treatment after three years...
December 06, 2025 09:30 ET | Source: Janssen Cilag International NV

Earlier use of CARVYKTI®▼ (ciltacabtagene autoleucel) demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma

Follow-up data from CARTITUDE-4 show at least 80 percent of as-treated standard-risk patients remained progression- and treatment-free following a single infusion as early as second line1 Data...
December 05, 2025 07:38 ET | Source: Research and Markets

Bio-Implants Market Set for a $245 Billion Valuation by 2030: Advanced 3D Printing Revolutionizes Bio-Implants with Tailored Solutions for Enhanced Patient Outcomes

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Bio-Implants Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering....
December 05, 2025 06:30 ET | Source: Research and Markets

$480+ Mn Rapid Liquid Printing Market - Global Forecasts from 2025 to 2030 Featuring Autodesk, Steelcase, 3D Systems, Materialise, BMW, MIT Self-Assembly Lab, Stratasys, EOS

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "Rapid Liquid Printing Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.The Rapid Liquid Printing...
December 04, 2025 09:30 ET | Source: Custom Market Insights

[Latest] Global 4D Printing in Healthcare Market Size/Share Worth USD 14240 Million by 2034 at a 84.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USa, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “4D Printing in Healthcare Market Size, Trends and Insights By Component...
November 28, 2025 04:16 ET | Source: Research and Markets

North America 3D Printing in Healthcare Market Analysis Report 2025-2033 Featuring 3D Systems, Exone, Formlabs, General Electric, Materialise, Oxferd Performance Materials, and Organovo

Dublin, Nov. 28, 2025 (GLOBE NEWSWIRE) -- The "North America 3D Printing in Healthcare Market Report by Offering, Technology, Application, Country and Company Analysis, 2025-2033" report has been...
November 26, 2025 01:05 ET | Source: CMB.TECH NV.

CMB.TECH announces Q3 2025 results

CMB.TECH ANNOUNCES Q3 2025 RESULTSSOFT SUMMER, FOLLOWED BY ROARING TANKER AND DRY BULK MARKETS ANTWERP, Belgium, 26 November 2025 – CMB.TECH NV (“CMBT”, “CMB.TECH” or “the Company”) (NYSE: CMBT,...